CDC-RFA-DP-23-0019: Outcomes Building Capacity to Reduce the Burden of Menthol and Other Flavored Commercial Tobacco Products in Communities that Experience Health Disparities
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Centers for Disease Control - NCCDPHP notices from 2023.
Centers for Disease Control - NCCDPHP offered grants of up to $750,000 (at least $300,000) to any type of organization. It expected to make about 8 awards worth $20.0 million in total. Applications closed on July 6, 2023.
From the official notice on Grants.gov, last changed May 4, 2023. Checked November 7, 2026.
- Award ceiling$750,000
- Award floor$300,000
- Total funding$20.0 million
- Expected awards8
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | May 4, 2023 |
|---|---|
| Deadline | July 6, 2023 |
| Archived by Grants.gov | August 3, 2023 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Applicants must be physically located and operate in the state, tribe, locality, or territory for which the work is proposed. Applicants must provide a statement that identifies the community and state, territory or tribe in which the applicant will do the proposed work. Applicant must provide proof of physical location (e.g., official letterhead, articles of incorporation, business card). This documentation must be labeled “Proposed_Work_Statement” and uploaded to www.grants.gov as a part of their application. See the glossary of this NOFO for the CDC definition of “community”.
Is this a realistic fit?
- Past National and State Tobacco Control Program awards averaged $4.1 million; this notice allows up to $750,000 per award.
- Most of the program's money (86% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
This Notice of Funding Opportunity (NOFO) seeks to build a community of practice of local, diverse community collaborators together with state tobacco control programs in order to: 1) develop and advance culturally competent commercial tobacco control policies, systems, and/or environmental interventions that reduce menthol and other flavored tobacco initiation and use among youth and increase motivation for adults to quit; 2) increase opportunities for culturally appropriate cessation support that increases the likelihood of sustained cessation for those who use menthol tobacco products, and; 3) initiate appropriate and culturally competent health communication interventions that evoke behavior change. This NOFO seeks to advance health equity through strategic partnerships, community engagement, and by addressing social determinants of health (SDOH) that contribute to menthol and other flavored tobacco product use.
Who has won National and State Tobacco Control Program grants before
From fiscal 2021 to 2025, National and State Tobacco Control Program (93.387) awarded $261 million across 63 grant awards, an average of $4.1 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| California Department of Public Health | California | 1 | $10.7 million |
| Department of State Health Services | Texas | 1 | $10.0 million |
| Health Research, Inc. | New York | 1 | $8.7 million |
| Florida Department of Health | Florida | 1 | $8.4 million |
| Ohio Department of Health | Ohio | 1 | $7.4 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-DP-23-0019 still open?
No. It closed on July 6, 2023.
Who can apply for Outcomes Building Capacity to Reduce the Burden of Menthol and Other Flavored Commercial Tobacco Products in Communities that Experience Health Disparities?
Centers for Disease Control - NCCDPHP accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Outcomes Building Capacity to Reduce the Burden of Menthol and Other Flavored Commercial Tobacco Products in Communities that Experience Health Disparities?
Closed July 6, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $750,000 each. About $20.0 million in total across about 8 awards.
Who has won National and State Tobacco Control Program grants before?
The largest recipients over five fiscal years were California Department of Public Health, Department of State Health Services, Health Research, Inc. The program made 63 awards worth $261 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)